本页面由Tiger Trade Technology Pte. Ltd.提供服务

Sensei Biotherapeutics, Inc.

13.85
0.0000
成交量:- -
成交额:- -
市值:1,856.32万
市盈率:-0.10
高:13.85
开:13.85
低:13.85
收:13.85
52周最高:36.76
52周最低:7.45
股本:134.03万
流通股本:81.09万
量比:2.41
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-142.7282
每股收益(LYR):-16.7239
净资产收益率:-195.26%
总资产收益率:-20.79%
市净率:0.11
市盈率(LYR):-0.83

数据加载中...

2026/06/18

重要事件披露

Form 8-K - Current report
2026/06/15

重要事件披露

Form 8-K - Current report
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/03

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/02

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/21

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/15

重要事件披露

Form 8-K - Current report
2026/04/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/16

重要事件披露

Form 8-K - Current report
2026/04/15

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/03/31

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/30

重要事件披露

Form 8-K - Current report
2026/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities